Esperion Therapeutics Inc. (ESPR) Financial Statements (2024 and earlier)

Company Profile

Business Address 3891 RANCHERO DRIVE, SUITE 150
ANN ARBOR, MI 48108
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments166,861259,333304,962200,781136,023200,199
Cash and cash equivalents124,775208,892304,962166,13036,97334,468
Short-term investments 42,08650,441 34,65199,050165,731
Receivables33,72922,934    
Inventory, net of allowances, customer advances and progress billings35,20134,39416,136   
Inventory35,20134,39416,136   
Other undisclosed current assets10,89212,31124,79810,9336,6093,725
Total current assets:246,683328,972345,896211,714142,632203,924
Noncurrent Assets
Operating lease, right-of-use asset1,0361,8986,0301,532
Property, plant and equipment 1646641,2761,145520435
Long-term investments and receivables     24373,420
Long-term investments     24373,420
Intangible assets, net (including goodwill), including:565656565656
Intangible assets, net (excluding goodwill) 565656565656
Other undisclosed intangible assets, net (including goodwill)      
Restricted cash and investments  50,000    
Total noncurrent assets:1,25652,6187,3622,73381973,911
TOTAL ASSETS:247,939381,590353,258214,447143,451277,835
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities58,23147,96976,76540,72748,29421,593
Accounts payable23,04017,55951,97528,85644,89320,375
Accrued liabilities35,19130,41024,79011,8713,4011,218
Deferred revenue3,5075,6831,6622,152
Debt    454 1,045
Other undisclosed current liabilities30,57019,70015,64222,74716,03910,506
Total current liabilities:92,30873,35294,06966,08064,33333,144
Noncurrent Liabilities
Long-term debt and lease obligation259,899258,804182,8211,109  
Long-term debt, excluding current maturities259,899258,280179,367   
Liabilities, other than long-term debt6656341,290   
Deferred revenue  634  
Other liabilities   1,290   
Operating lease, liability6655243,4541,109
Other undisclosed noncurrent liabilities218,845245,744171,212127,308  
Total noncurrent liabilities:479,409505,182355,323128,417  
Total liabilities:571,717578,534449,392194,49764,33333,144
Equity
Equity, attributable to parent(323,778)(196,944)(96,134)19,95079,118244,691
Common stock756126272726
Treasury stock, value(54,998)(54,998)(54,998)   
Additional paid in capital1,071,183964,401797,655715,166677,511641,801
Accumulated other comprehensive income (loss) (2)(31) 23(319)(845)
Accumulated deficit(1,340,036)(1,106,377)(838,817)(695,266)(598,101)(396,291)
Total equity:(323,778)(196,944)(96,134)19,95079,118244,691
TOTAL LIABILITIES AND EQUITY:247,939381,590353,258214,447143,451277,835

Income Statement (P&L) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues75,47578,447227,547148,364  
Gross profit:75,47578,447227,547148,364  
Operating expenses(254,976)(305,177)(348,943)(241,465)(204,585)(168,982)
Operating loss:(179,501)(226,730)(121,396)(93,101)(204,585)(168,982)
Nonoperating income
(Other Nonoperating income)
2,6523,9755154,0562,7752,192
Interest and debt expense(56,810)(46,353)(22,670)(8,120) (198)
Loss from continuing operations:(233,659)(269,108)(143,551)(97,165)(201,810)(166,988)
Loss before gain (loss) on sale of properties:(269,108)(143,551)(97,165)(201,810)(166,988)
Net loss available to common stockholders, diluted:(233,659)(269,108)(143,551)(97,165)(201,810)(166,988)

Comprehensive Income ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(233,659)(269,108)(143,551)(97,165)(201,810)(166,988)
Comprehensive loss:(233,659)(269,108)(143,551)(97,165)(201,810)(166,988)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent29(31)(23)342526(673)
Comprehensive loss, net of tax, attributable to parent:(233,630)(269,139)(143,574)(96,823)(201,284)(167,661)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: